ClinicalVentricular TachycardiaStereotactic arrhythmia radioablation for refractory scar-related ventricular tachycardia
Introduction
Stereotactic radiosurgery is a form of radiotherapy that is performed in a single session and focuses high-dose ionizing radiation beams from a collimated radiation source to a small localized area of the body. In contrast to traditional radiotherapy, which functions by disrupting cellular division, radiosurgery works by creating radiation-induced necrosis.1 Stereotactic radiosurgery is currently used for the treatment of various types of tumors in the head and neck, lung, abdomen, pelvis, and spine, with good local control rates and minimal side effects.2 Stereotactic arrhythmia radioablation (STAR) is the application of stereotactic radiosurgery for the noninvasive treatment of cardiac arrhythmias. STAR has been used to homogenize the scar in patients with structural heart disease and ventricular tachycardia (VT) that is refractory to antiarrhythmic drugs (AADs) and has failed radiofrequency catheter ablation (RFCA), with promising results.3, 4, 5, 6, 7, 8, 9, 10
In this report, we describe our experience with STAR, detailing its early and mid- to long-term results, which adds to the existing body of knowledge of radiation therapy applied to patients with ventricular arrhythmias.
Section snippets
Patient population
This was a prospective, single-arm, 2-center feasibility study of STAR for the treatment of refractory scar-related VT. Patients referred by an electrophysiologist to our center to be considered for radioablation were screened and considered for the study if they met all the following criteria: (1) presence of an implantable cardioverter-defibrillator (ICD), (2) ischemic or nonischemic cardiomyopathy with recurrent symptomatic VT that induced ICD shock(s) despite RFCA and/or AAD therapy, (3)
Results
Between January and June 2018, 6 patients were screened and enrolled in the study in 1 center. One patient was subsequently excluded because of preexisting chronic renal failure, with inability to undergo serial CT imaging with contrast at follow-up. Five patients underwent STAR, and their demographic and clinical characteristics are outlined in Table 1. An enrollment exception was made for 2 patients younger than 60 years, one of whom experienced recurrent sustained symptomatic VT episodes
Discussion
In this pilot study, STAR performed with CyberKnife, resulted in an initial decrease in ventricular arrhythmia burden in all patients, but significant recurrence was ineluctable by the end of 1-year follow-up. Of note, this is the first study to report unfavorable efficacy outcomes after radioablation, but it is important to note that follow-up times as well as definition of success and radiosurgical technologies differ among different studies, so a direct comparison is speculative at this
Conclusion
Despite good initial results, STAR did not result in effective ventricular arrhythmia control in the long term in a selected high-risk population of patients with scar-related VT. The safety profile of STAR was confirmed to be favorable, with no radiation-related complications observed during the first year of follow-up. Further studies are needed to explain these disappointing results.
References (24)
- et al.
Rescue procedure for an electrical storm using robotic non-invasive cardiac radio-ablation
Radiother Oncol
(2018) - et al.
Risen from the dead: cardiac stereotactic ablative radiotherapy as last rescue in a patient with refractory ventricular fibrillation storm
HeartRhythm Case Rep
(2019) - et al.
Clinical experience of stereotactic body radiation for refractory ventricular tachycardia in advanced heart failure patients
Heart Rhythm
(2020) - et al.
Synchrony—Cyberknife respiratory compensation technology
Med Dosim
(2008) - et al.
Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)
Int J Radiat Oncol
(1995) - et al.
Dose-escalation study for cardiac radiosurgery in a porcine model
Int J Radiat Oncol
(2014) - et al.
Cardiac remodeling—concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling
J Am Coll Cardiol
(2000) - et al.
Radiobiological basis of SBRT and SRS
Int J Clin Oncol
(2014) Developments in stereotactic body radiotherapy
Cancers
(2018)- et al.
Cardiac radiosurgery for malignant ventricular tachycardia
Cureus
(2014)
Stereotactic ablative radiotherapy for the treatment of refractory cardiac ventricular arrhythmia
Circ Arrhythm Electrophysiol
Noninvasive cardiac radiation for ablation of ventricular tachycardia
N Engl J Med
Cited by (0)
This study was sponsored by CyberHeart.
Drs Gardner and Maguire are employees of CyberHeart. Dr Gardner has intellectual and equity interests in CyberHeart. Drs Al-Ahmad and Zei received research and travel support from CyberHeart. The rest of the authors report no conflicts of interest.